Toronto - Delayed Quote • CAD
HLS Therapeutics Inc. (HLS.TO)
At close: 3:05 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 3 |
| Avg. Estimate | -0.25 | -0.23 | -0.68 | -0.42 |
| Low Estimate | -0.27 | -0.23 | -0.88 | -0.75 |
| High Estimate | -0.23 | -0.23 | -0.47 | -0.23 |
| Year Ago EPS | -0.24 | -0.4 | -1.16 | -0.68 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 4 |
| Avg. Estimate | 19.95M | 21.32M | 87.65M | 100.83M |
| Low Estimate | 19.19M | 20.69M | 86.47M | 99.9M |
| High Estimate | 20.56M | 21.93M | 88.67M | 101.41M |
| Year Ago Sales | 19.59M | -- | 86.44M | 87.65M |
| Sales Growth (year/est) | 1.80% | -- | 1.40% | 15.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.17 | -0.13 | -0.13 |
| EPS Actual | -0.24 | -0.4 | -0.28 | -0.23 |
| Difference | -0.09 | -0.23 | -0.15 | -0.1 |
| Surprise % | -60.00% | -135.30% | -115.40% | -76.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.23 | -0.68 | -0.42 |
| 7 Days Ago | -0.25 | -0.23 | -0.68 | -0.42 |
| 30 Days Ago | -0.25 | -0.23 | -0.74 | -0.5 |
| 60 Days Ago | -0.11 | -0.09 | -0.37 | -0.07 |
| 90 Days Ago | -0.11 | -0.09 | -0.39 | -0.07 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HLS.TO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -4.20% | -- | -- | 6.50% |
| Next Qtr. | 42.50% | -- | -- | 12.00% |
| Current Year | 41.40% | -- | -- | 5.30% |
| Next Year | 38.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | 3.25% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Raymond James: Market Perform to Market Perform | 3/18/2024 |
| Downgrade | Raymond James: Outperform to Market Perform | 8/6/2021 |
Related Tickers
VPH.TO Valeo Pharma Inc.
0.1150
+21.05%
MDP.TO Medexus Pharmaceuticals Inc.
1.9200
+3.23%
ZLSCF ZYUS Life Sciences Corporation
0.8000
0.00%
ZYUS.V ZYUS Life Sciences Corporation
1.0500
+3.96%
VEXT.CN Vext Science, Inc.
0.2400
+2.13%
VIV.V Avivagen Inc.
0.0050
0.00%
CPH.TO Cipher Pharmaceuticals Inc.
8.50
0.00%
PBH Prestige Consumer Healthcare Inc.
70.47
+0.47%
WLLW.TO Willow Biosciences Inc.
0.0900
0.00%
GUD.TO Knight Therapeutics Inc.
5.73
+0.70%